Case number 1:18-cv-00690
Vanda Pharmaceuticals Inc. v. MSN Pharmaceuticals Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 19, 2022 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per the entry of the Consent Judgment in Lead Case No. 18-651-CFC. (nmf) |
| Sep 28, 2020 | 136 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants MSN Pharmaceuticals, Inc. and MSN Laboratories Private Limited's First Supplemental Responses to Vanda's First Set of Interrogatories to MSN (Nos. 1-3) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Sep 16, 2020 | 135 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants MSN Pharmaceuticals, Inc. and MSN Laboratories Private Limited's Responses to Vanda's First Set of Interrogatories to MSN (Nos. 1-3) Regarding U.S. Patent Nos. 10,376,487 and 10,449,176 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| May 5, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:19-cv-00926-CFC, 19 in 1:19-cv-00560-CFC, 20 in 1:19-cv-00685-CFC) Joint STIPULATION & Proposed Order for Consolidation by Vanda Pharmaceuticals Inc., (20 in 1:20-cv-00235-CFC, 129 in 1:18-cv-00651-CFC, 25 in 1:19-cv-02202-CFC, 133 in 1:18-cv-00690-CFC, 21 in 1:20-cv-00093-CFC, 132 in 1:18-cv-00689-CFC, 20 in 1:20-cv-00083-CFC, 23 in 1:19-cv-02375-CFC, 18 in 1:20-cv-00318-CFC) Stipulation filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 5/5/2020. Associated Cases: 1:18-cv-00651-CFC et al.(nmf) |
| May 5, 2020 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-00651-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO 18-651-CFC ONLY. (nmf) |
| Apr 21, 2020 | 132 | Stipulation (4) Docket Text: Joint STIPULATION of Proposed Amended Schedule by Vanda Pharmaceuticals Inc.. (Jacobs, Karen) |
| Apr 21, 2020 | 133 | Stipulation (4) Docket Text: Joint STIPULATION & Proposed Order for Consolidation by Vanda Pharmaceuticals Inc.. (Jacobs, Karen) |
| Apr 21, 2020 | 134 | SO ORDERED (4) Docket Text: SO ORDERED, re (131 in 1:18-cv-00689-CFC, 128 in 1:18-cv-00651-CFC, 132 in 1:18-cv-00690-CFC) Stipulation filed by Vanda Pharmaceuticals Inc., SCHEDULING ORDER: Expert Discovery due by 4/30/2021., A Final Pretrial Conference is set for 6/30/2021 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly., A Bench Trial is set for 7/19/2021 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 4/21/2020. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Apr 16, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: On or before April 23, 2020, the parties shall submit a revised proposed scheduling order incorporating the new hearing dates as discussed during the scheduling teleconference in the related civil actions on April 2, 2020. Ordered by Judge Colm F. Connolly on 4/16/2020. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Apr 2, 2020 | N/A | Remark (0) Docket Text: Remark: Counsel shall submit a proposed revised scheduling order incorporating the new pretrial conference and trial dates given during the scheduling conference in the related civil actions today. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Apr 1, 2020 | 131 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Report of Dr. Charles A. Czeisler, (2) Report of Dr. Steven W. Lockley, (3) Report of Dr. Andrew Parkinson, (4) Report of Dr. Henry G. Grabowski, and (5) Report of Dr. Stephen C. Bergmeier filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Mar 31, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [130] MOTION for Pro Hac Vice Appearance of Attorney Elizabeth E. Grden filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 3/31/2020. (fms) |
| Mar 31, 2020 | 130 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Elizabeth E. Grden - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # (1) Certification of Elizabeth E. Grden)(Bilson, David) |
| Mar 31, 2020 | 130 | Certification of Elizabeth E. Grden (1) |
| Mar 30, 2020 | 129 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Expert Report of Deborah Jaskot 2) Rebuttal Expert Report of Dr. Robert B. Perni Regarding Non-Infringement of U.S. Patent No. 10,071,977 3) First Expert Report of Dr. John W. Winkelman filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Mar 27, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (128 in 1:18-cv-00689-CFC, 125 in 1:18-cv-00651-CFC, 128 in 1:18-cv-00690-CFC) Joint STIPULATION to Extend Expert Discovery Deadlines. Signed by Judge Colm F. Connolly on 3/27/2020. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Mar 27, 2020 | 128 | Stipulation (3) Docket Text: Joint STIPULATION to Extend Expert Discovery Deadlines by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Mar 18, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (127 in 1:18-cv-00689-CFC, 124 in 1:18-cv-00651-CFC, 127 in 1:18-cv-00690-CFC) Joint STIPULATION to Extend Expert Discovery Deadlines. Signed by Judge Colm F. Connolly on 3/18/2020. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Mar 18, 2020 | 127 | Stipulation (4) Docket Text: Joint STIPULATION to Extend Expert Discovery Deadlines by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Mar 3, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (123 in 1:18-cv-00651-CFC, 126 in 1:18-cv-00690-CFC, 126 in 1:18-cv-00689-CFC) Stipulation of Proposed Amended Schedule filed by Vanda Pharmaceuticals Inc.. Signed by Judge Colm F. Connolly on 3/3/2020. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Mar 2, 2020 | 126 | Stipulation (4) Docket Text: Joint STIPULATION of Proposed Amended Schedule by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Feb 6, 2020 | 125 | Redacted Document (4) Docket Text: REDACTED VERSION of [121] Stipulation by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Bilson, David) |
| Feb 4, 2020 | 124 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Invalidity Expert Report of Dr. Robert B. Perni Regarding U.S. Patent No. 10,071,977 (2) First Expert Report of Dr. Jonathan Emens (4) Opening Expert Report of David J. Greenblatt, M.D. filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jan 31, 2020 | 122 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Report of Daniel Combs, M.D. and (2) Report of Stephen C. Bergmeier, Ph.D. Regarding Infringement by MSN of U.S. Patent No. 10,071,977 filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Jan 24, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (120 in 1:18-cv-00651-CFC, 120 in 1:18-cv-00690-CFC, 123 in 1:18-cv-00689-CFC) STIPULATION TO EXTEND TIME of Certain Deadlines for Expert Discovery to various dates (see Stipulation) filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 1/24/2020. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Jan 24, 2020 | 120 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME of Certain Deadlines for Expert Discovery to various dates (see Stipulation) - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Dec 23, 2019 | 118 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendants Second Supplemental Invalidity Contentions Concerning U.S. Patent No. 10,071,977 2) Defendants Second Amended Invalidity Contentions Regarding U.S. Patent No. 10,149,829 3) Defendants Third Amended Invalidity Contentions filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Dec 23, 2019 | 119 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) MSN's [HIGHLY CONFIDENTIAL] Supplemental Responses to Vanda's Second Set of Interrogatories to MSN (Nos. 7 & 8); and (2) MSN's [HIGHLY CONFIDENTIAL] Supplemental Responses to Vanda's Second Set of Joint Interrogatories to Defendants (Nos. 9 & 10) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Dec 20, 2019 | 117 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Second Supplemental Objections and Responses to Defendants' First Set of Joint Interrogatories to Vanda (No. 3) filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Dec 18, 2019 | 116 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Supplemental Objections and Responses to Defendants' First Set of Joint Interrogatories to Vanda (Nos. 1-4, 6-8, and 10) filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Dec 10, 2019 | 115 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Vanda's Supplemental Infringement Contentions for U.S. Patent No. 10,071,977 to Teva; and (2) Vanda's Supplemental Infringement Contentions for U.S. Patent No. 10,071,977 to MSN filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Dec 3, 2019 | 114 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' Supplemental Invalidity Contentions Concerning U.S. Patent No. 10,071,977; (2) Defendants' Amended Invalidity Contentions Regarding U.S. Patent No. 10,149,829; and (3) Defendants' Second Amended Invalidity Contentions filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Dec 2, 2019 | 113 | Notice of Service (7) Docket Text: NOTICE OF SERVICE of Plaintiff's Responses to Discovery Requests filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Nov 27, 2019 | 112 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) MSN's Responses to Vanda's Second Set of Interrogatories to MSN (Nos. 7 & 8); (2) MSN's [HIGHLY CONFIDENTIAL] Supplemental Responses to Vanda's First Set of Joint Interrogatories to Defendants (Nos. 1-8); and (3) MSN's Responses to Vanda's Second Set of Joint Interrogatories to Defendants (Nos. 9 & 10) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Nov 13, 2019 | 111 | SO ORDERED (4) Docket Text: SO ORDERED, re (114 in 1:18-cv-00689-CFC, 110 in 1:18-cv-00690-CFC, 108 in 1:18-cv-00651-CFC) STIPULATION TO EXTEND TIME of Certain Scheduling Order Deadlines to various dates (see Stipulation) filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 11/13/2019. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Nov 12, 2019 | 110 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME of Certain Scheduling Order Deadlines to various dates (see Stipulation) - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Oct 31, 2019 | 108 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited's Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Oct 31, 2019 | 109 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Responses and Objections to Defendants' Notice of Rule 30(b)(6) Deposition of Vanda Pharmaceuticals Inc. filed by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Oct 29, 2019 | 107 | SO ORDERED (8) Docket Text: SO ORDERED, re (106 in 1:18-cv-00690-CFC, 104 in 1:18-cv-00651-CFC, 108 in 1:18-cv-00689-CFC) CLAIM CONSTRUCTION ORDER. Signed by Judge Colm F. Connolly on 10/29/2019. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Oct 25, 2019 | 106 | Proposed Order (8) Docket Text: PROPOSED ORDER /Proposed Claim Construction Order by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Oct 18, 2019 | 105 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Subpoenas to Testify at a Deposition in a Civil Action directed to Marlene Dressman, Louis Licamele, John Feeney III, Stephen F. Swinton Jr., and Natalie M. Platt filed by Apotex Corp., Apotex Inc..(Francella, Thomas) |
| Oct 16, 2019 | 103 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited's First Set of Requests for Admission (Nos. 1-156) and First Set of Interrogatories to Plaintiff filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Oct 16, 2019 | 104 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' First Set of Joint Requests for Admission (Nos. 1-20) to Plaintiff (2) Defendants' Second Set of Joint Interrogatories to Plaintiff (3) Defendants' Joint Second Set of Requests for the Production of Documents and Things to Plaintiff (Nos. 109-146) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Oct 15, 2019 | 98 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of (1) Vanda's Second Set of Joint Interrogatories to Defendants (Nos. 9-10), (2) Vanda's First Set of Interrogatories to Teva (Nos. 1 & 2), (3) Vanda's Second Set of Interrogatories to Apotex (Nos. 2 & 3) and (4) Vanda's Second Set of Interrogatories to MSN (Nos. 7 & 8) filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Oct 15, 2019 | 100 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Kondal Reddy Bairy on November 8, 2019 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Oct 15, 2019 | 101 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Bharat Reddy Chintapally on November 6, 2019 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Oct 15, 2019 | 102 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Manthena China Satyanarayana Raju on November 4, 2019 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Oct 14, 2019 | 93 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Rosarelis Torres on November 4, 2019 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Oct 14, 2019 | 94 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Jim Kelly on November 6, 2019 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Oct 14, 2019 | 95 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Mihael Polymeropoulos on November 5, 2019 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Oct 14, 2019 | 96 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Ravi K. Pandrapragada on November 12, 2019 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Oct 14, 2019 | 97 | Notice to Take Deposition (3) Docket Text: NOTICE to Take Deposition of Deepak Phadke on November 14, 2019 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Oct 10, 2019 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Markman Hearing held on 10/10/2019. (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Oct 2, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (88 in 1:18-cv-00651-CFC, 93 in 1:18-cv-00689-CFC, 91 in 1:18-cv-00690-CFC) MOTION for Pro Hac Vice Appearance of Attorney Sasha Rao filed by Teva Pharmaceuticals USA, Inc. Signed by Judge Colm F. Connolly on 10/2/2019. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Oct 2, 2019 | 92 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' Notice of Rule 30(b)(6) Deposition of Vanda Pharmaceuticals, Inc. filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 1, 2019 | 91 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Sasha Rao - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Aug 20, 2019 | 90 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Amended Invalidity Contentions filed by Apotex Corp., Apotex Inc., Teva Pharmaceuticals USA, Inc., MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Aug 12, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (86 in 1:18-cv-00651-CFC, 89 in 1:18-cv-00690-CFC, 91 in 1:18-cv-00689-CFC) STIPULATION TO EXTEND TIME for Substantial Completion of Document Production to August 30, 2019 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 8/12/2019. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Aug 12, 2019 | 89 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME for Substantial Completion of Document Production to August 30, 2019 - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Bilson, David) |
| Jul 29, 2019 | 88 | Motion for Miscellaneous Relief (2) Docket Text: MOTION Defendants' Motion for Claim Construction re [84] Claim Construction Chart - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Phillips, John) |
| Jul 26, 2019 | 84 | Claim Construction Chart (30) Docket Text: CLAIM Construction Chart by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jul 26, 2019 | 85 | Claim Construction Opening Brief (30) Docket Text: CLAIM CONSTRUCTION OPENING BRIEF /Joint Claim Construction Brief filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jul 26, 2019 | 86 | Main Document (5) Docket Text: APPENDIX re (83 in 1:18-cv-00651-CFC) Claim Construction Opening Brief, (85 in 1:18-cv-00690-CFC) Claim Construction Opening Brief, (88 in 1:18-cv-00689-CFC) Claim Construction Opening Brief /Appendix of Exhibits by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Exhibits 1-3, # (2) Exhibits 4-7, # (3) Exhibit 8, # (4) Exhibits 9-13)(Fahnestock, Derek) |
| Jul 26, 2019 | 86 | Exhibits 1-3 (120) |
| Jul 26, 2019 | 86 | Exhibits 4-7 (133) |
| Jul 26, 2019 | 86 | Exhibit 8 (151) |
| Jul 26, 2019 | 86 | Exhibits 9-13 (106) |
| Jul 26, 2019 | 87 | Motion for Miscellaneous Relief (4) Docket Text: MOTION Claim Construction re (87 in 1:18-cv-00689-CFC, 82 in 1:18-cv-00651-CFC, 84 in 1:18-cv-00690-CFC) Claim Construction Chart /Vanda's Motion on Claim Construction - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jul 19, 2019 | 83 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions Regarding U.S. Patent No. 10,149,829 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Jul 12, 2019 | 82 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Sur-Reply Construction Brief filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Jul 3, 2019 | 81 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Vanda's Objections and Responses to Defendants' Joint First Set of Requests for Production of Documents (Nos. 1-108) and (2) Vanda's Objections and Responses to Defendants' First Set of Joint Interrogatories to Vanda (Nos. 1-10) filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jun 20, 2019 | 80 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) MSN's Responses to Vanda's First Set of Joint Requests for Admission to Defendants (No. 1); (2) MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited's Responses to Vanda's First Set of Interrogatories to MSN (Nos. 1-6); and (3) MSN's [HIGHLY CONFIDENTIAL - ATTORNEYS' EYES ONLY] Responses to Vanda's First Set of Joint Interrogatories to Defendants (Nos. 1-8) filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Jun 18, 2019 | 79 | Objections (10) Docket Text: ANSWER to Counterclaims by Vanda Pharmaceuticals Inc. /Plaintiff's Answer to Defendants' Counterclaims (linked to DI 8 in CA 19-926). (Fahnestock, Derek) Modified on 6/18/2019 (fms). |
| Jun 14, 2019 | 78 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Reply Claim Construction Brief filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jun 12, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Eric A. Stone,Josephine Young,Kira A. Davis,Nicholas Groombridge for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (fms) |
| Jun 12, 2019 | 76 | SO ORDERED (4) Docket Text: SO ORDERED, re (15 in 1:19-cv-00926-CFC, 75 in 1:18-cv-00690-CFC) Stipulation Regarding Consolidation filed by Vanda Pharmaceuticals Inc. C.A. No. 19-926 (CFC) shall be consolidated with C.A. No. 18-690 (CFC) for all purposes. All filings shall be in C.A. No. 18-690 (CFC). Signed by Judge Colm F. Connolly on 6/12/2019. Associated Cases: 1:18-cv-00690-CFC, 1:19-cv-00926-CFC(fms) |
| Jun 12, 2019 | 77 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Infringement Contentions filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jun 10, 2019 | 75 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order Regarding Consolidation of Cases by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jun 3, 2019 | 74 | SO ORDERED (6) Docket Text: SO ORDERED, re (15 in 1:19-cv-00560-CFC, 10 in 1:19-cv-00926-CFC, 72 in 1:18-cv-00651-CFC, 76 in 1:18-cv-00689-CFC, 73 in 1:18-cv-00690-CFC, 16 in 1:19-cv-00685-CFC) Joint STIPULATION regarding Case Schedule and Claim Construction for U.S. Patent No. 10,149,829. Signed by Judge Colm F. Connolly on 6/3/2019. Associated Cases: 1:18-cv-00651-CFC et al.(nmf) |
| May 31, 2019 | 73 | Stipulation (6) Docket Text: Joint STIPULATION regarding Case Schedule and Claim Construction for U.S. Patent No. 10,149,829 by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| May 20, 2019 | 72 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' [CONFIDENTIAL] First Set of Joint Interrogatories to Plaintiff and [CONFIDENTIAL] Joint First Requests for the Production of Documents and Things to Plaintiff (Nos. 1-108) filed by Apotex Corp., Apotex Inc., Teva Pharmaceuticals USA, Inc., MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| May 17, 2019 | 71 | Disclosure Statement (4) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock, Inc. for Vanda Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Vanda Pharmaceuticals Inc. filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| May 14, 2019 | 70 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of (1) Vanda's First Set of Joint Interrogatories to Defendants (Nos. 1-8) and (2) Vanda's First Set of Joint Requests for Admission to Defendants (No. 1), (3) Vanda's First Set of Interrogatories to Apotex (No. 1) and (4) Vanda's First Set of Interrogatories to MSN (Nos. 1-6) filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Apr 12, 2019 | 69 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Opening Claim Construction Brief filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Mar 13, 2019 | 66 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants MSN Pharmaceuticals, Inc. and MSN Laboratories Private Limited's Supplemental Rule 26(a)(1) Initial Disclosures and Supplemental Disclosures Under Paragraph 3 of the Default Standard for Discovery filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Mar 13, 2019 | 67 | Claim Construction Chart (30) Docket Text: CLAIM Construction Chart by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Mar 13, 2019 | 68 | Main Document (5) Docket Text: APPENDIX re (67 in 1:18-cv-00690-CFC, 66 in 1:18-cv-00651-CFC, 70 in 1:18-cv-00689-CFC) Claim Construction Chart /Appendix of Exhibits to Joint Claim Construction Chart by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Exhibits 1-3, # (2) Exhibits 4-5, # (3) Exhibits 6-7, # (4) Exhibit 8, Pt 1, # (5) Exhibit 8, Pt 2, # (6) Exhibits 9-13)(Fahnestock, Derek) |
| Mar 13, 2019 | 68 | Exhibits 1-3 (120) |
| Mar 13, 2019 | 68 | Exhibits 4-5 (79) |
| Mar 13, 2019 | 68 | Exhibits 6-7 (54) |
| Mar 13, 2019 | 68 | Exhibit 8, Pt 1 (79) |
| Mar 13, 2019 | 68 | Exhibit 8, Pt 2 (80) |
| Mar 13, 2019 | 68 | Exhibits 9-13 (117) |
| Mar 8, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (65 in 1:18-cv-00690-CFC, 65 in 1:18-cv-00651-CFC, 69 in 1:18-cv-00689-CFC) Joint STIPULATION TO EXTEND TIME to submit Joint Claim Construction Chart and Intrinsic Evidence to March 13, 2019 filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 3/8/2019. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Mar 7, 2019 | 65 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME to submit Joint Claim Construction Chart and Intrinsic Evidence to March 13, 2019 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Mar 1, 2019 | 63 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiff Vanda Pharmaceuticals Inc.'s Claim Construction Intrinsic Evidence Disclosure filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Mar 1, 2019 | 64 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Intrinsic Evidence in Support of Proposed Claim Constructions filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Feb 15, 2019 | 61 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Preliminary Proposed Claim Constructions for Claim Term(s)/Phrase(s) Identified by the Parties filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Feb 15, 2019 | 62 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiff Vanda Pharmaceuticals Inc.'s Claim Construction Disclosure filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Feb 12, 2019 | 59 | Protective Order (28) Docket Text: STIPULATED PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 2/12/2019. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Feb 12, 2019 | 60 | Main Document (4) Docket Text: REDACTED VERSION of (60 in 1:18-cv-00689-CFC, 56 in 1:18-cv-00690-CFC, 56 in 1:18-cv-00651-CFC) Letter to The Honorable Colm F. Connolly regarding Protective Order Dispute by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Exhibits 1-6)(Fahnestock, Derek) |
| Feb 12, 2019 | 60 | Exhibits 1-6 (80) |
| Feb 11, 2019 | 57 | Proposed Order (28) Docket Text: PROPOSED ORDER /[Proposed] Stipulated Protective Order by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Feb 11, 2019 | 58 | Redacted Document (30) Docket Text: REDACTED VERSION of (55 in 1:18-cv-00690-CFC, 55 in 1:18-cv-00651-CFC, 58 in 1:18-cv-00689-CFC) Letter by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) |
| Feb 7, 2019 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Discovery Conference held on 2/7/2019. (Court Reporter V. Gunning.) Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Feb 1, 2019 | 54 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of a Letter to All Defendants Regarding Claim Terms to be Construed filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jan 30, 2019 | 53 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of (1) Plaintiff Vanda Pharmaceuticals Inc.'s Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and (2) Vanda Pharamceuticals Inc.'s Supplemental Disclosures Pursuant to Delaware Default Standard for Discovery Including Discovery of Electronically Stored Information filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jan 25, 2019 | 52 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions Concerning U.S. Patent No. 10,071,977 filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Jan 9, 2019 | 50 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited's [CONFIDENTIAL] Objections and Responses to Plaintiff's First Set of Requests for the Production of Documents and Things filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Jan 9, 2019 | 51 | Answer to Counterclaim (26) Docket Text: ANSWER to [49] Answer to Amended Complaint, Counterclaim / Plaintiff's Answer to Defendants' Counterclaims by Vanda Pharmaceuticals Inc..(Jacobs, Karen) |
| Dec 28, 2018 | N/A | Set/Reset Hearings (0) Docket Text: Set Hearings: A Discovery Conference is set per request of counsel for 2/7/2019 at 04:00 PM in Courtroom 4B before Judge Colm F. Connolly. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Dec 26, 2018 | 49 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [43] Amended Complaint , Affirmative Defenses and, COUNTERCLAIM against Vanda Pharmaceuticals Inc. by MSN Pharmaceuticals Inc., MSN Laboratories Private Limited.(Phillips, John) |
| Dec 21, 2018 | 47 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Initial Infringement Contentions for U.S. Patent No. 10, 071,977 filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Dec 21, 2018 | 48 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' Identification of E-mail Custodians filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Dec 19, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (46 in 1:18-cv-00690-CFC, 50 in 1:18-cv-00689-CFC, 45 in 1:18-cv-00651-CFC) STIPULATION TO EXTEND TIME to Submit Protective Order to December 27, 2018 filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 12/19/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Dec 18, 2018 | 46 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit Protective Order to December 27, 2018 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Dec 13, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (45 in 1:18-cv-00690-CFC, 49 in 1:18-cv-00689-CFC, 44 in 1:18-cv-00651-CFC) STIPULATION TO EXTEND TIME to Identify E-Mail Custodians to December 21, 2018 filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 12/13/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Dec 12, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. Nos. [43] and [44] have been re-docketed by docket clerk. The correct docket event to docket an Amended Complaint is COMPLAINT - AMENDED. (fms) |
| Dec 12, 2018 | 45 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Identify E-Mail Custodians to December 21, 2018 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Dec 11, 2018 | N/A | Remark (0) Docket Text: Remark: The deputy clerk is unable to docket the amended complaint in this case as the pdf attached to the stipulation contains the incorrect case number. It lists Vanda Pharmaceuticals v. MSN Pharmaceuticals Inc., et al., under Civil Action No. 18-689-CFC, but the caption should contain Civil Action No. 18-690-CFC. Counsel is directed to electronically file a corrected version of the amended complaint and attached exhibits by the close of business 12/12/2018 in accordance with Judge Connolly's order and also to docket an amended patent report. (nmf) |
| Dec 11, 2018 | 41 | Order (5) Docket Text: ORDER approving JOINT STIPULATION TO AMEND COMPLAINT (43 in 1:18-cv-00689-CFC), (39 in 1:18-cv-00690-CFC), (38 in 1:18-cv-00651-CFC). Signed by Judge Colm F. Connolly on 12/11/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Dec 11, 2018 | 42 | Scheduling Order (5) Docket Text: AMENDED SCHEDULING ORDER re: Stipulation: Fact Discovery completed by 11/15/2019. Expert Discovery due by 4/24/2020. A Markman Hearing is set for 10/10/2019 at 01:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Final Pretrial Conference is set for 9/24/2020 at 04:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 10/5/2020 at 09:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 12/11/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Dec 11, 2018 | 43 | Main Document (40) Docket Text: FIRST AMENDED COMPLAINT against MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.- filed by Vanda Pharmaceuticals Inc. (Attachments: # (1) Exhibits A-G)(fms) |
| Dec 11, 2018 | 43 | Exhibits A-G (252) |
| Dec 11, 2018 | 44 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): RE46,604 ;9,060,995 ;9,539,234 ;9,549,913 ;9,730,910 ;9,855,241 ;10,071,977 Adding 10,071,977 by Amended Complaint. (fms) |
| Dec 11, 2018 | 43 | Amended Complaint* (1) |
| Dec 11, 2018 | 43 | Amended Complaint* (1) |
| Dec 7, 2018 | 39 | Main Document (5) Docket Text: Joint STIPULATION to Amend Complaint re [1] Complaint, by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Exhibit 1- Teva First Amended Complaint, # (2) Exhibit Combined Exhibits A-G, # (3) Exhibit 2- Apotex First Amended Complaint, # (4) Exhibit Combined Exhibits A-G, # (5) Exhibit 3 - MSN First Amended Complaint, # (6) Exhibit Combined Exhibits A-G)(Fahnestock, Derek) |
| Dec 7, 2018 | 39 | Exhibit 1- Teva First Amended Complaint (41) |
| Dec 7, 2018 | 39 | Exhibit Combined Exhibits A-G (252) |
| Dec 7, 2018 | 39 | Exhibit 2- Apotex First Amended Complaint (45) |
| Dec 7, 2018 | 39 | Exhibit Combined Exhibits A-G (252) |
| Dec 7, 2018 | 39 | Exhibit 3 - MSN First Amended Complaint (45) |
| Dec 7, 2018 | 39 | Exhibit Combined Exhibits A-G (252) |
| Dec 7, 2018 | 40 | Stipulation (5) Docket Text: Joint STIPULATION Proposed Amended Schedule by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Dec 5, 2018 | 38 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's First Set of Requests for Production of Documents and Things filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Dec 3, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (37 in 1:18-cv-00690-CFC, 36 in 1:18-cv-00651-CFC, 41 in 1:18-cv-00689-CFC) STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to December 18, 2018 filed by Vanda Pharmaceuticals Inc.. Signed by Judge Colm F. Connolly on 12/3/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Nov 30, 2018 | 37 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit a Proposed Protective Order to December 18, 2018 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Nov 27, 2018 | 36 | SO ORDERED (5) Docket Text: SO ORDERED, re (35 in 1:18-cv-00690-CFC, 34 in 1:18-cv-00651-CFC, 39 in 1:18-cv-00689-CFC) Stipulation and Order on E-Mail Discovery. Signed by Judge Colm F. Connolly on 11/27/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Nov 21, 2018 | 35 | Stipulation (5) Docket Text: STIPULATION on E-Mail Discovery by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Nov 20, 2018 | 34 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Nov 13, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (37 in 1:18-cv-00689-CFC, 32 in 1:18-cv-00651-CFC, 33 in 1:18-cv-00690-CFC) STIPULATION TO EXTEND TIME for the parties to submit a stipulation related to electronic discovery to November 23, 2018 filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 11/13/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Nov 9, 2018 | 33 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a stipulation related to electronic discovery to November 23, 2018 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Nov 2, 2018 | 32 | Order Setting Mediation Conferences (5) Docket Text: ORDER Setting Mediation Conference: A Telephone Conference is set for 12/3/2018 at 11:45 AM before Judge Christopher J. Burke to discuss ADR. Signed by Judge Christopher J. Burke on 11/2/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(dlb) |
| Nov 1, 2018 | N/A | Remark (0) Docket Text: Remark: The docket text of the scheduling order has been updated to include the notation that the Judge made revisions to paragraph 8 and also to include the Joint Claim Construction Brief deadline to the text of the entry. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Nov 1, 2018 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(cak) |
| Nov 1, 2018 | 31 | Scheduling Order (11) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 2/28/2019. Amended Pleadings due by 2/28/2019. Fact Discovery completed by 8/2/2019. Joint Claim Construction Brief due by 4/17/2019. A Markman Hearing is set for 5/20/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Final Pretrial Conference is set for 5/28/2020 at 04:30 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 6/15/2020 at 09:30 AM in Courtroom 4B before Judge Colm F. Connolly. See revisions to paragraph 8. Signed by Judge Colm F. Connolly on 10/31/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Oct 26, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (30 in 1:18-cv-00690-CFC, 34 in 1:18-cv-00689-CFC, 29 in 1:18-cv-00651-CFC) Joint STIPULATION TO EXTEND TIME to submit a Stipulation relating to Electronic Discovery to November 9, 2018 filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 10/26/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Oct 25, 2018 | 30 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME to submit a Stipulation relating to Electronic Discovery to November 9, 2018 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Oct 23, 2018 | 29 | Main Document (11) Docket Text: PROPOSED ORDER /Proposed Scheduling Order by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Cover Letter)(Fahnestock, Derek) |
| Oct 23, 2018 | 29 | Cover Letter (1) |
| Oct 17, 2018 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 10/17/2018. (Court Reporter V. Gunning.) Counsel to submit the final proposed scheduling order to the Court. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Oct 15, 2018 | 28 | Main Document (11) Docket Text: PROPOSED ORDER /Proposed Scheduling Order by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Cover letter)(Fahnestock, Derek) |
| Oct 15, 2018 | 28 | Cover letter (1) |
| Oct 12, 2018 | N/A | Set/Reset Deadlines (0) Docket Text: Reset Deadline per D.I. [27]: Thirty Month Stay Deadline: 7/31/2021. In the future, counsel should file this form using the code ANDA Form, found under OTHER FILINGS, OTHER DOCUMENTS. (fms) |
| Oct 12, 2018 | 27 | Statement (3) Docket Text: STATEMENT re [3] ANDA Form, [Corrected Supplemental Information for Patent Cases Involving an Abbreviated New Drug Application (ANDA)] by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Oct 11, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [26] Joint STIPULATION TO EXTEND TIME to Submit a Stipulation Related to Electronic Discovery to October 25, 2018 filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 10/11/2018. (fms) |
| Oct 10, 2018 | 26 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME to Submit a Stipulation Related to Electronic Discovery to October 25, 2018 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Oct 4, 2018 | 25 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Vanda's Infringement Contentions filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Sep 28, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (24 in 1:18-cv-00690-CFC, 27 in 1:18-cv-00689-CFC, 23 in 1:18-cv-00651-CFC) STIPULATION TO EXTEND TIME to Submit a Stipulation Related to Electronic Discovery to October 11, 2018 filed by Vanda Pharmaceuticals Inc. Signed by Judge Colm F. Connolly on 9/28/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(fms) |
| Sep 27, 2018 | 24 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Submit a Stipulation Related to Electronic Discovery to October 11, 2018 - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Sep 26, 2018 | N/A | Set/Reset Hearings (0) Docket Text: Reset Hearings: The Scheduling Conference is rescheduled per request of counsel for 10/17/2018 at 10:00 AM in Chambers before Judge Colm F. Connolly Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Sep 24, 2018 | 23 | Status Report (7) Docket Text: Joint STATUS REPORT by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Sep 20, 2018 | 22 | Order Setting Scheduling Conference (2) Docket Text: Order Setting Scheduling Conference: A Scheduling Conference is set for 10/16/2018 at 02:00 PM in Chambers before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 9/20/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Sep 11, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Case Management Conference set for 9/17/18 before Judge Burke has been cancelled in light of the case no longer being referred. Ordered by Judge Christopher J. Burke on 9/11/2018. Associated Cases: 1:18-cv-00689-CFC, 1:18-cv-00651-CFC, 1:18-cv-00690-CFC(dlb) |
| Sep 10, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER by Judge Colm F. Connolly on 9/10/2018: In light of the reassignment of these cases, the Court HEREBY ORDERS that the prior referral to Magistrate Judge Christopher J. Burke is withdrawn, with the exception that any referral to Judge Burke for ADR shall remain in place. Associated Cases: 1:18-cv-00651-CFC-CJB, 1:18-cv-00689-CFC-CJB, 1:18-cv-00690-CFC-CJB(nmf) |
| Sep 10, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Pursuant to the reassignment of this action, the parties shall submit a joint status report on or before September 24, 2018. Please identify in the status report the next event the parties believe the Court needs to schedule. (Status Report due by 9/24/2018.) Ordered by Judge Connolly 9/10/2018. Associated Cases: 1:18-cv-00651-CFC, 1:18-cv-00689-CFC, 1:18-cv-00690-CFC(nmf) |
| Sep 6, 2018 | 21 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Identification of Accused Products and Asserted Patents and (2) Production of File Histories filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Aug 31, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:18-cv-00651-CFC-CJB, 1:18-cv-00689-CFC-CJB, 1:18-cv-00690-CFC-CJB (rjb) |
| Aug 28, 2018 | N/A | Order Setting Scheduling Conference (0) Docket Text: Oral Order Resetting Telephonic Scheduling Conference: At the request of counsel, the Case Management/Scheduling Conference set for 9/10/2018 has been reset for 9/17/2018 at 02:00 PM before Judge Christopher J. Burke. Ordered by Judge Christopher J. Burke on 8/28/2018. Associated Cases: 1:18-cv-00651-VAC-CJB, 1:18-cv-00689-VAC-CJB, 1:18-cv-00690-VAC-CJB(dlb) |
| Aug 28, 2018 | 19 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) Plaintiff Vanda Pharmaceuticals Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and (2) Vanda Pharmaceuticals Inc.s Disclosures Pursuant to Delaware Default Standard for Discovery Including Discovery of Electronically Stored Information filed by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Aug 28, 2018 | 20 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited's Rule 26(a)(1) Initial Disclosures; and (2) Defendants MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited's Initial Disclosures Under Paragraph 3 of the Default Standard for Discovery filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Bilson, David) |
| Aug 27, 2018 | 18 | Letter (1) Docket Text: Letter to The Honorable Christopher J. Burke from Derek J. Fahnestock regarding Rescheduling Scheduling Teleconference - re Order Setting Scheduling Conference, Order Setting Scheduling Conference,. (Fahnestock, Derek) |
| Aug 22, 2018 | N/A | Order Setting Scheduling Conference (0) Docket Text: Oral Order Setting Telephonic Case Management/Scheduling Conference: A Case Management/Scheduling Conference is set for 9/10/2018 at 02:00 PM before Judge Christopher J. Burke. Signed by Judge Christopher J. Burke on 8/22/2018. Associated Cases: 1:18-cv-00651-VAC-CJB, 1:18-cv-00689-VAC-CJB, 1:18-cv-00690-VAC-CJB(dlb) Modified on 8/22/2018 (dlb). |
| Aug 22, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Oral Order setting the Case Management/Scheduling Conference has been changed to reflect correct the date. Associated Cases: 1:18-cv-00651-VAC-CJB, 1:18-cv-00689-VAC-CJB, 1:18-cv-00690-VAC-CJB(dlb) |
| Aug 15, 2018 | 16 | Letter (8) Docket Text: Letter to The Honorable Christopher J. Burke from Derek J. Fahnestock regarding Case Management Issues. (Fahnestock, Derek) |
| Aug 15, 2018 | 17 | Main Document (15) Docket Text: PROPOSED ORDER /Scheduling Order by Vanda Pharmaceuticals Inc.. (Attachments: # (1) Cover letter)(Fahnestock, Derek) |
| Aug 15, 2018 | 17 | Cover letter (1) |
| Aug 13, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Daniel J. Klein for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Aug 9, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] MOTION for Pro Hac Vice Appearance of Attorney Jennifer Rea Deneault of Paul, Weiss, Rifkind, Wharton & Garrison LLP filed by Vanda Pharmaceuticals Inc. Ordered by Judge Christopher J. Burke on 8/9/2018. (crb) |
| Aug 9, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jennifer R. Deneault for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| Jul 26, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. (13 in 1:18-cv-00651-VAC-CJB, 17 in 1:18-cv-00689-VAC-CJB, 14 in 1:18-cv-00690-VAC-CJB) STIPULATION TO EXTEND TIME re Scheduling Deadlines to various dates (see Stipulation) filed by Vanda Pharmaceuticals Inc. Ordered by Judge Christopher J. Burke on 7/23/2018. Associated Cases: 1:18-cv-00651-VAC-CJB, 1:18-cv-00689-VAC-CJB, 1:18-cv-00690-VAC-CJB(dlb) |
| Jul 23, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Bryce A. Cooper for MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Jul 23, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kevin E. Warner for MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Jul 23, 2018 | 15 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jennifer Rea Deneault of Paul, Weiss, Rifkind, Wharton & Garrison LLP - filed by Vanda Pharmaceuticals Inc.. Motions referred to Christopher J. Burke.(Jacobs, Karen) |
| Jul 20, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [12] MOTION for Pro Hac Vice Appearance of Attorney Kevin E. Warner, Bryce A. Cooper and Reid F. Smith filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc., [8] MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Kira A. Davis, Josephine Young and Daniel J. Klein of Paul, Weiss, Rifkind, Wharton & Garrison LLP filed by Vanda Pharmaceuticals Inc. Ordered by Judge Christopher J. Burke on 7/20/2018. (dlb) |
| Jul 20, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Reid Smith for MSN Laboratories Private Limited,Reid Smith for MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (fms) |
| Jul 20, 2018 | 14 | Stipulation to EXTEND Time (4) Docket Text: STIPULATION TO EXTEND TIME re Scheduling Deadlines to various dates (see Stipulation) - filed by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| Jul 19, 2018 | 13 | Answer to Counterclaim (19) Docket Text: ANSWER to [10] Answer to Complaint, Counterclaim by Vanda Pharmaceuticals Inc..(Fahnestock, Derek) |
| Jul 11, 2018 | 12 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kevin E. Warner, Bryce A. Cooper and Reid F. Smith - filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Attachments: # (1) Certification of Kevin E. Warner, # (2) Certification of Bryce A. Cooper, # (3) Certification of Reid F. Smith)Motions referred to Christopher J. Burke.(Bilson, David) |
| Jul 11, 2018 | 12 | Certification of Kevin E. Warner (1) |
| Jul 11, 2018 | 12 | Certification of Bryce A. Cooper (1) |
| Jul 11, 2018 | 12 | Certification of Reid F. Smith (1) |
| Jun 29, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the parties shall meet and confer and discuss, in person and/or by telephone, each of the matters listed on Judge Burkes Case Management Checklist (Checklist). Within thirty (30) days from the date of this Order, the parties shall jointly file the following: (I) a copy of the Checklist, indicating the names of Lead Counsel and Delaware Counsel for each party; (ii) a proposed Scheduling Order consistent with Judge Burkes Rule 16 Scheduling Order Patent; and (iii) a letter, not to exceed three pages, that contains the following: (a) a description of what this case is about; (b) the parties positions regarding any disputes in the proposed Scheduling Order, and (c) a list of the three most significant topics (other than Scheduling Order disputes) discussed during the parties review of the Checklist items, along with a brief description as to what was discussed as to those topics. Thereafter, the Court may schedule an in-person Case Management Conference/Rule 16 Scheduling Conference to be held with Judge Burke. The Checklist and Rule 16 Scheduling Order Patent can be found on this Court's website (http://www.ded.uscourts.gov/judge/magistrate-judge-christopher-j-burke). Ordered by Judge Christopher J. Burke on 6/29/2018. (dlb) |
| Jun 28, 2018 | 10 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM against Vanda Pharmaceuticals Inc. by MSN Pharmaceuticals Inc., MSN Laboratories Private Limited.(Phillips, John) |
| Jun 28, 2018 | 11 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Private Limited for MSN Pharmaceuticals Inc. filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc.. (Phillips, John) |
| May 23, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED D.I. [9] Stipulation regarding Service and Answer deadlines for MSN filed by Vanda Pharmaceuticals Inc. Ordered by Judge Christopher J. Burke on 5/23/2018. (dlb) |
| May 23, 2018 | 9 | Stipulation (2) Docket Text: STIPULATION regarding Service by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) |
| May 14, 2018 | 8 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Kira A. Davis, Josephine Young and Daniel J. Klein of Paul, Weiss, Rifkind, Wharton & Garrison LLP - filed by Vanda Pharmaceuticals Inc.. Motions referred to Christopher J. Burke.(Jacobs, Karen) |
| May 10, 2018 | N/A | Remark re Newer Attorneys (0) Docket Text: REMARK: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:http://www.ded.uscourts.gov/sites/default/files/forms/StandingOrder2017.pdf (dlb) |
| May 10, 2018 | N/A | Remark (0) Docket Text: REMARK: If the parties jointly consent to have a Magistrate Judge conduct all proceedings in this case, including trial, then when Judge Burke enters a case schedule he will enter the respective pre-trial conference and trial dates onto his calendar and will honor them. Otherwise, in accordance with the District Court's procedures for "Assignment of Cases to Visiting Judges" (issued on May 26, 2017 and available on the District Court's website), then upon the filing of a case-dispositive motion (e.g., a motion to dismiss, a motion for judgment on the pleadings, a motion for summary judgment, or initiation of the claim construction process in a patent case), VAC cases will be considered ready for reassignment to a visiting District Judge. Whether the pre-trial conference and trial dates will stand after reassignment will depend on the availability of those dates on the visiting District Judge's calendar. (dlb) |
| May 9, 2018 | N/A | Set/Reset Deadlines (0) Docket Text: Reset Deadlines: Thirty Month Stay Deadline: 10/2/2020. (fms) |
| May 9, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The ANDA form at D.I. [3] has been removed and replaced per request of filer. The docket text and deadlines have been corrected. (fms) |
| May 9, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Vacant Judgeship (2017). Please include initials of VAC after the case number on all documents filed. Associated Cases: 1:18-cv-00689-VAC, 1:18-cv-00690-VAC (rjb) |
| May 9, 2018 | N/A | Case Referred to Magistrate Judge (0) Docket Text: CASE REFERRED to Magistrate Judge Christopher J. Burke. (This matter has been assigned to the Vacant Judgeship and referred to a Magistrate Judge for handling through case-dispositive motions. The Magistrate Judge has full authority permitted by law to manage this matter, including entering schedules through trial, deciding non-dispositive matters and making recommendations as to the resolution of dispositive matters. Litigants and counsel are reminded that they have the option of consenting to the Magistrate Judge to handle the case in full, including trial, or consenting to having a particular motion resolved by the Magistrate Judge.) Associated Cases: 1:18-cv-00689-VAC, 1:18-cv-00690-VAC(rjb) |
| May 9, 2018 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Vanda Pharmaceuticals Inc.. MSN Pharmaceuticals Inc. served on 5/8/2018, answer due 5/29/2018. (Jacobs, Karen) |
| May 9, 2018 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Vanda Pharmaceuticals Inc.. MSN Laboratories Private Limited served on 5/8/2018, answer due 5/29/2018. (Jacobs, Karen) |
| May 7, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to MSN Laboratories Private Limited on 5/7/2018; MSN Pharmaceuticals Inc. on 5/7/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (crb) |
| May 7, 2018 | 1 | Main Document (37) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2376865.) - filed by Vanda Pharmaceuticals Inc. (Attachments: # (1) Exhibit A - F, # (2) Civil Cover Sheet)(crb) |
| May 7, 2018 | 1 | Exhibit A - F (241) |
| May 7, 2018 | 1 | Civil Cover Sheet (2) |
| May 7, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (crb) |
| May 7, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/2/2018. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 10/2/2020. (crb) (Main Document 3 replaced on 5/9/2018) (fms). Modified on 5/9/2018 (fms). |
| May 7, 2018 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE46,604; 9,060,995; 9,539,234; 9,549,913; 9,730,910; 9,855,241. (crb) |
| May 7, 2018 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Vanda Pharmaceuticals Inc. (crb) |
| May 7, 2018 | 1 | Complaint* (1) |
